NORTHWEST BIOTHERAPEUTICS INC: cash_and_equivalents
| Value | {"amount": 6963000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | NORTHWEST BIOTHERAPEUTICS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/076f81ee-e4f8-4d32-8d2f-a587ef90500d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001410578-22-001218 · Open the official SEC filing →Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001072379/cash-and-equivalents/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/076f81ee-e4f8-4d32-8d2f-a587ef90500d
History
- no predecessors — first report